학술논문

SPX-101 is a novel epithelial sodium channel–targeted therapeutic for cystic fibrosis that restores mucus transport
Document Type
Article
Source
In: American Journal of Respiratory and Critical Care Medicine. (American Journal of Respiratory and Critical Care Medicine, 15 September 2017, 196(6):734-744)
Subject
Language
English
ISSN
15354970
1073449X